Patents by Inventor Guy T. Carter
Guy T. Carter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 5510251Abstract: This invention relates to new agents designated LL-F28249.alpha., LL-F28249.beta., LL-F28249.gamma., LL-F28249.delta., LLF28249.epsilon., LL-F28249.zeta., LL-F28249.eta., LL-F28249.theta., LL-F28249.iota., LL-F28249.kappa., LL-F28249.lambda., LL-F28249.mu., LL-F28249.nu., and LL-F28249.omega., to their production by fermentation, to methods for their recovery and concentration from crude solutions, to processes for their purification and to pharmaceutically and pharmacologically-acceptable salts thereof. The present invention includes within its scope the biologically pure culture which produces there agents, derived from a newly-discovered and previously uncultured microorganism, Streptomyces cyaneogriseus subsp. noncyanogenus, NRRL 15773.Type: GrantFiled: October 4, 1994Date of Patent: April 23, 1996Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Margaret J. Torrey, Michael Greenstein
-
Patent number: 5432193Abstract: This invention relates to antibiotic LL-D37187.alpha. derived from the microorganism Streptomyces which is useful as an antibacterial agent.Type: GrantFiled: May 14, 1993Date of Patent: July 11, 1995Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Gerhard Schlingmann, David P. Labeda, Joseph J. Goodman
-
Patent number: 5418168Abstract: This invention relates to new agents designated LL-F28249.alpha., LL-F28249.beta., LL-F28249.gamma., LL-F28249.delta., LL-F28249.epsilon., LL-F28249.zeta., LL-F28249.eta., LL-F28249.theta., LL-F28249.iota., LL-F28249.kappa., LL-F28249.lambda., LL-F28249.mu., LL-F28249.nu., and LL-F28249.omega., to their production by fermentation, to methods for their recovery and concentration from crude solutions, to processes for their purification and to pharmaceutically and pharmacologically-acceptable salts thereof. The present invention includes within its scope the biologically pure culture which produces there agents, derived from a newly-discovered and previously uncultured microorganism, Streptomyces cyaneogriseus subsp. noncyanogenus, NRRL 15773.Type: GrantFiled: August 10, 1992Date of Patent: May 23, 1995Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Margaret J. Torrey, Michael Greenstein
-
Patent number: 5286745Abstract: The invention provides antibiotics designated LL-E19020 Epsilon and LL-E19020 Epsilon.sub.1 which are derived from the microorganism Streptomyces lydicus ssp. tanzanius NRRL 18036.Type: GrantFiled: September 9, 1991Date of Patent: February 15, 1994Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Joseph J. Goodman
-
Patent number: 5223430Abstract: This disclosure describes novel antibacterial agents designated LL-E10985.alpha., LL-E19085.beta., LL-E19085.gamma., LL-E19085.zeta. and LL-E19085.eta., having the structure: ##STR1## their production by aerobic fermentation of a new subspecies of Micromonospora citrea NRRL 18351 and mutants thereof, and the isolation and purification thereof.Type: GrantFiled: October 28, 1991Date of Patent: June 29, 1993Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Joseph J. Goodman, David P. Labeda
-
Patent number: 5188945Abstract: The invention provides an improved process for the isolation and purification of antibiotics designated LL-E19020 alpha and beta which are derived from the microorganism Streptomyces lydicus ssp. tanzanius NRRL 18036.The invention is a method of recovery, concentration from crude solutions and to processes for the purification of anitbiotics designated LL-E19020 alpha and beta which are derived from the microorganism Streptomyces lydicus ssp. tanzanius NRRL 18036.Type: GrantFiled: September 9, 1991Date of Patent: February 23, 1993Assignee: American Cyanamid CompanyInventors: Guy T. Carter, David R. Williams, Fernando Pinho
-
Patent number: 5169956Abstract: This invention relates to new agents designated LL-F28249.alpha., LL-F28249.beta., LL-F28249.gamma., LL-F28249.delta., LL-F28249.epsilon., LL-F28249.zeta., LL-F28249.eta., LL-F28249.theta., LL-F28249.iota., LL-F28249.kappa., LL-F28249.lambda., LL-F28249.mu., LL-F28249.nu., and LL-F2924.omega., to their production by fermentation, to methods for their recovery and concentration from crude solutions, to processes for their purification and to pharmaceutically and pharmacologically-acceptable salts thereof. The present invention includes within its scope the biologically pure culture which produces there agents, derived from a newly-discovered and previously uncultured microorganism, Streptomyces cyaneogriseus subsp. noncyanogenus, NRRL 15773.Type: GrantFiled: June 25, 1990Date of Patent: December 8, 1992Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Margaret J. Torrey, Michael Greenstein
-
Patent number: 5106994Abstract: This invention relates to new agents designated LL-F28249.alpha., LL-F28249.beta., LL-F28249.gamma., LL-F28249.delta., LLF28249.epsilon., LL-F28249.zeta., LL-F28249.eta., LL-F28249.theta., LL-F28249.iota., LL-F28249.kappa., LL-F28249.lambda., LL-F28249.mu., LL-F28249.nu., and LL-F28249.omega., to their production by fermentation, to methods for their recovery and concentration from crude solutions, to processes for their purification and to pharmaceutically and pharmacologically-acceptable salts thereof. The present invention includes within its scope the biologically pure culture which produces there agents, derived from a newly-discovered and previously uncultured microorganism, Streptomyces cyaneogriseus subsp. noncyanogenus, NRRL 15773.Type: GrantFiled: May 10, 1985Date of Patent: April 21, 1992Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Margaret J. Torrey, Michael Greenstein
-
Patent number: 5096907Abstract: This disclosure describes novel antibacterial agents designated LL-E10985.alpha., LL-E19085.beta., LL-E19085.gamma., LL-E19085.gamma. and LL-E19085.zeta., having the structure: ##STR1## their production by aerobic fermentation of a new subspecies of Micromonospora citrea NRRL 18351 and mutants thereof, and the isolation and purification thereof.Type: GrantFiled: January 9, 1991Date of Patent: March 17, 1992Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Joseph J. Goodman, David P. Labeda
-
Patent number: 5077277Abstract: Derivatives of antibiotics derived from the microorganism Streptomyces lydicus subspecies tanzanius, referred to as antibiotics LL-E19020 alpha and beta, are produced by chemical reaction. The derivatives are also active antibiotics useful in the treatment of bacterial infections.Type: GrantFiled: September 5, 1989Date of Patent: December 31, 1991Assignee: American Cyanamid CompanyInventors: Douglas W. Phillipson, Guy T. Carter, Donald B. Borders
-
Patent number: 4968493Abstract: This invention provides a method for treating chronic respiratory disease, fowl cholera and necrotic enteritis in infected birds, by orally administering thereto a pharmaceutically effective amount of antibiotic LL-E19020.alpha., antibiotic LL-E19020.beta. or a physiologically acceptable salt thereof.Type: GrantFiled: June 19, 1989Date of Patent: November 6, 1990Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Michael Greenstein, Joseph J. Goodman, Donald B. Borders, William M. Maiese, Raymond T. Testa
-
Patent number: 4859598Abstract: Antibiotic LL-D42067.beta. derived by aerobic fermentation of the microorganism Actinomadura madurae subspecies simaoensis NRRL 15734, useful as an antibacterial and antiparasitic agent.Type: GrantFiled: January 21, 1986Date of Patent: August 22, 1989Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Donald B. Borders, Joseph J. Goodman, David P. Labeda
-
Patent number: 4762949Abstract: Synthetically produced substantially pure biologically active compounds having the general formula ##STR1## wherein R.sub.1 is C.sub.1 -C.sub.20 alkyl, alkenyl, aryl, aralkyl, cycloalkyl, alkylcycloalkyl, cycloalkylalkyl, cycloalkenyl, alkylcycloalkenyl, or cycloalkenylalkyl;R.sub.2 is hydrogen, C.sub.1 -C.sub.10 alkyl or an amide-substituted alkyl having up to 10 carbon atoms;R.sub.3 is a cyclic, straight or branched chain hydrocarbon group having 2-12 carbon atoms, particularly --(CH.sub.2).sub.n --, wherein n is 2-12; orR.sub.2 and R.sub.3 are linked together to form an alkylene chain; andR.sub.4 is selected from ##STR2## (substituted or unsubstituted carbamimidoyl), ##STR3## (dimethylpyrimidyl), or ##STR4## (carbamyl) wherein each of R.sub.5, R.sub.6, and R.sub.7 is hydrogen or the same or different C.sub.1 -C.sub.8 alkyl group. The compounds are useful as bactericides for a wide variety of bacteria, including S.pyogenes, B.subtilis, K.pneumoniae, M.avium, B.fragilis, C.perfringens and C.albicans.Type: GrantFiled: January 24, 1983Date of Patent: August 9, 1988Assignee: University of Illinois FoundationInventors: Kenneth L. Rinehart, Jr., Guy T. Carter, Michael T. Cheng
-
Patent number: 4705688Abstract: This invention relates to antibiotic LL-E19020.alpha. and LL-E19020.beta. derived from the microorganism Streptomyces lydicus subspecies tanzanius NRRL 18036, which are useful as an antibacterial agent.Type: GrantFiled: June 30, 1986Date of Patent: November 10, 1987Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Michael Greenstein, Joseph J. Goodman, Donald B. Borders, William M. Maiese, Raymond T. Testa
-
Patent number: 4578468Abstract: Antibiotic LL-D42067.beta. derived by aerobic fermentation of the microorganism Actinomadura madurae subspecies simaoensis NRRL 15734, useful as an antibacterial and antiparasitic agent.Type: GrantFiled: March 26, 1984Date of Patent: March 25, 1986Assignee: American Cyanamid CompanyInventors: Guy T. Carter, Donald B. Borders, Joseph J. Goodman, David P. Labeda